Lorviqua

Lorviqua (lorlatinib) is an oral medication used to treat certain types of cancer. It works by targeting specific proteins involved in cancer cell growth. This medication is manufactured by Pfizer Europe Ma Eeig.

Lorviqua is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or returned. It is designed to target specific genetic mutations that drive cancer growth. Patients may wonder, 'What is Lorviqua used for?'—it is intended for those who have previously undergone other treatments without success.

Common effects of Lorviqua may include fatigue, swelling, and changes in mood. Some users might experience weight gain or cognitive changes. These effects can vary widely among individuals and are not exhaustive.

Lorviqua should be handled with care, following the guidance of a healthcare professional. It is important to discuss any pre-existing conditions or other medications being taken to ensure safe use. Regular monitoring may be recommended.

Lorviqua can interact with certain medications, including those that affect liver enzymes. Alcohol and other substances may also influence its effectiveness or increase the risk of side effects. Always consult a healthcare provider before combining treatments.